Next Treatments
Back to Eczema

LNK01001

TypePill StagePhase 3 Latest updateJan 12, 2026Phase 3 study completed

History

Earliest recorded event: Jan 26, 2022. This timeline shows events collected by Eczema Radar and may not include the treatment’s full history. Study details reflect the latest registry record available here.

  • Jan 12, 2026Phase 3 trial completedA Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis. ClinicalTrials.gov NCT06277245
  • Apr 18, 2025Phase 3 main data collectedA Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis. ClinicalTrials.gov NCT06277245
  • Feb 6, 2024Phase 3 trial startedA Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis. ClinicalTrials.gov NCT06277245
  • Jun 14, 2023Phase 2 trial completedA Study of LNK01001 Capsule in Patients With Moderate to Severe Atopic Dermatitis ClinicalTrials.gov NCT06085521
  • Jan 26, 2022Phase 2 trial startedA Study of LNK01001 Capsule in Patients With Moderate to Severe Atopic Dermatitis ClinicalTrials.gov NCT06085521

Sources

Trials